Medicxi backs siR­NA-fo­cused Alde­na Ther­a­peu­tics with $30M

With a $30 mil­lion in­fu­sion in­to Alde­na Ther­a­peu­tics by Medicxi, siR­NA-based ther­a­pies are mov­ing in­to der­ma­tol­ogy.

Alde­na, found­ed in 2021, plans to use its pipeline …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER